We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Abbott Labs to Focus on Devices, Sells Generic Drug Group for $5.3B
Abbott Labs to Focus on Devices, Sells Generic Drug Group for $5.3B
Abbott Laboratories is sharpening its focus on devices and diagnostics, selling its developed markets generic drug business to Mylan for $5.3 billion in stock.